LANDMARK trial: Early outcomes of a randomised non-inferiority trial comparing TAVI devices

Описание к видео LANDMARK trial: Early outcomes of a randomised non-inferiority trial comparing TAVI devices

Results of the LANDMARK trial, presented by Patrick Serruys: Previous head-to-head comparisons of new THVs with established devices confirmed no class effect of clinical benefits after TAVI with inferior safety & efficacy for some of them. Validation of MyVal non-inferiority to the most widely used balloon-expandable and self-expandable platforms is therefore significant.

More news: https://www.pcronline.com/News/Whats-...

Комментарии

Информация по комментариям в разработке